160 likes | 306 Views
Cervical cancer Mexico’s experience. Dr. Maki Esther Ortiz Domínguez Viceminister of Integration and Development of the Public Health Sector Mexican Ministry of Health. Rate per 100,000 women mortality of cervical cancer. 260 thousand deaths, per year.
E N D
Cervical cancerMexico’s experience Dr. Maki Esther Ortiz Domínguez Viceminister of Integration and Development of the Public Health Sector Mexican Ministry of Health
Rate per 100,000 women mortality of cervical cancer 260 thousand deaths, per year. Rates per 100,000 women per year. Standardised rates have been estimated using the direct method and the World population as the reference. Data sources:IARC, Globocan 2008. Age-specific data from GLOBOCAN 2008 were obtained from IARC, personal communication.
Cases of cervical cancer Most of the cases are detected in the developing countries. Rates per 100,000 women per year. Standardised rates have been estimated using the direct method and the World population as the reference. Data sources:IARC, Globocan 2008. Age-specific data from GLOBOCAN 2008 were obtained from IARC, personal communication.
Mexico:Principal causes of death in women, 2009 Types of Cancer
Cervical cancer trends progress in Mexico Mortality rate per 100,000 women mortality from breast and cervical cancer National policy (Official Mexican Standard: NOM-014) Source: Knaul FM, et. al., Salud Pública de México, 2009.
Mortality rate of women aged 25 and over From 19.57 to 13.75 in 10 years
National policy Official Mexican Standard (NOM-014) for Prevention, Treatment and Control of Cervical Cancer. • Education for the population to get awareness, and self responsibility. • Cytological sample as universal detection method. • Positive HPV sent to a colposcopy center.
Sonora Prevention and early detection actions • PAP screening implemented in all public health care services. 35% detection coverage in 1989, • 75% detection coverage in 2010. • 13 Cytology laboratories (tests of HPV DNA to high risk women from 35 to 64 years). Nuevo León Edo México Sinaloa Campeche DF Veracruz Jalisco Puebla Guanajuato Michoacán Guerrero Oaxaca
Hybrid Capture Test • Started in 2007 • Applied in 125 counties with less Human Development Index • 2009-2010: 1.9 millions tests in all country to women from 35 – 64 years old. • 2011: 2 millions of tests.
Home vaginal self take test: Advantages • More accuracy and sensitivity to identify NIC2+, and cervical injuries. • Quick increase of coverage • Available technology in the poorest areas • Better diagnosis quality that only use of PAP.
VPH Vaccine (Recombinant Human Papillomavirus Quadrivalent Vaccine) • Started in 2008. • Complete schemes of 3 doses of HPV vaccine. • 125 regions (municipalities) with the lowest human development index. • 400,000 complete schemes of VPH vaccines to girls from 9 – 12 years old in 2008-2010. • 20 % coverage in girls 9-12 years old.
Actions for the poorest women in poor communities • “Caravanas de la Salud” Program • Health promotion • HPV Vaccination • Cervical Cytology and Acid Acetic direct visualization. • Biomolecular tests: Hybrid Capture, and RPC (Resistive plate chambers), as a cytology complement. • Women in 25 to 64 years with positive results, are referred to a Colposcopy Center, Dysplasia center, or a Oncological Center.
Treatment of Cervical cancer • Universal financial coverage of treatment since 2004 to 2010. • 12,251 cases under “Seguro Popular” coverage to women without any health insurance.
Goals and perspective • Incorporate the HPV vaccine to the basic vaccination scheme. • Reach in 5 years, a coverage detection for high risk HPV of 65 % in 35-64 women. • National goal 2012: Reduce mortality to 10.9 deaths per 100,000 women aged 25 and over (27% from 2006 to 2012). • Continue efforts to reach levels of developed countries with death rates per 100,000 women (3 to 5).
Cervical cancer is preventable using the available screening, diagnosis and treatment.
Health is not everything, but without health, everything is nothing. (Schopenhauer)